{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:03:02Z","timestamp":1791302582303,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Quinazolines are nitrogen-containing heterocycles that consist of a benzene ring fused with a pyrimidine ring. Quinazolinones, oxidized quinazolines, are promising compounds with a wide range of biological activities. In the pharmaceutical field, quinazolinones are the building blocks of more than 150 naturally occurring alkaloids isolated from different plants, microorganisms, and animals. Scientists give a continuous interest in this moiety due to their stability and relatively easy methods for preparation. Their lipophilicity is another reason for this interest as it helps quinazolinones in penetration through the blood\u2013brain barrier which makes them suitable for targeting different central nervous system diseases. Various modifications to the substitutions around the quinazolinone system changed their biological activity significantly due to changes in their physicochemical properties. Structure\u2013activity relationship (SAR) studies of quinazolinone revealed that positions 2, 6, and 8 of the ring systems are significant for different pharmacological activities. In addition, it has been suggested that the addition of different heterocyclic moieties at position 3 could increase activity. In this review, we will highlight the chemical properties of quinazolinones, including their chemical reactions and different methods for their preparation. Moreover, we will try to modify some of the old SAR studies according to their updated biological activities in the last twelve years.<\/jats:p>","DOI":"10.3390\/molecules28030978","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:22:10Z","timestamp":1674109330000},"page":"978","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Quinazolinones, the Winning Horse in Drug Discovery"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-5141","authenticated-orcid":false,"given":"Aishah M.","family":"Alsibaee","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11564, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-5814","authenticated-orcid":false,"given":"Hanan M.","family":"Al-Yousef","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11564, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda S.","family":"Al-Salem","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11564, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Implication of Quinazoline-4(3H)-Ones in Medicinal Chemistry: A Brief Review","volume":"1","author":"Pradhan","year":"2016","journal-title":"J. Chem. Biol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.1016\/j.tet.2005.07.010","article-title":"Synthesis of Quinazolinones and Quinazolines","volume":"61","author":"Connolly","year":"2005","journal-title":"Tetrahedron"},{"key":"ref_3","first-page":"13","article-title":"Chemistry Structure Activity Relationship and Biological Activity of Quinazoline-4 (3H)-One Derivatives","volume":"2","author":"Mahato","year":"2011","journal-title":"Inven. Rapid Med Chem"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/cr020033s","article-title":"The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures","volume":"103","author":"Horton","year":"2003","journal-title":"Chem. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejmech.2014.02.005","article-title":"Recent Advances in the Structural Library of Functionalized Quinazoline and Quinazolinone Scaffolds: Synthetic Approaches and Multifarious Applications","volume":"76","author":"Khan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_6","first-page":"1","article-title":"Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives","volume":"2014","author":"Asif","year":"2014","journal-title":"Int. J. Med. Chem."},{"key":"ref_7","first-page":"93","article-title":"Pyrimidines and Their Benzo Derivatives","volume":"6","author":"Undheim","year":"2009","journal-title":"Compr. Heterocycl. Chem. II"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12065","DOI":"10.1039\/C4RA00351A","article-title":"Recent Advances in 4(3H)-Quinazolinone Syntheses","volume":"4","author":"He","year":"2014","journal-title":"RSC Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/AAC.49.3.1169-1176.2005","article-title":"Antimalarial Activities and Therapeutic Properties of Febrifugine Analogs. Antimicrob","volume":"49","author":"Jiang","year":"2005","journal-title":"Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1016\/j.ejmech.2010.05.040","article-title":"Synthesis and Evaluation of 4-Quinazolinone Compounds as Potential Antimalarial Agents","volume":"45","author":"Zhu","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.bmc.2014.02.040","article-title":"The Chemistry and Biology of Febrifugine and Halofuginone","volume":"22","author":"McLaughlin","year":"2014","journal-title":"Bioorganic Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12582","DOI":"10.1021\/acs.jmedchem.1c00441","article-title":"Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials","volume":"64","author":"Laleu","year":"2021","journal-title":"J Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1007\/s00044-014-1020-2","article-title":"Synthesis of Novel Isoniazid Incorporated Styryl Quinazolinones as Anti-Tubercular Agents against INH Sensitive and MDR M. Tuberculosis Strains","volume":"23","author":"Babu","year":"2014","journal-title":"Med. Chem. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2015.03.014","article-title":"Synthesis, Crystal Structure and Biological Evaluation of Substituted Quinazolinone Benzoates as Novel Antituberculosis Agents Targeting Acetohydroxyacid Synthase","volume":"94","author":"Lu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00894-013-1820-1","article-title":"Synthesis and Biological Evaluation of Cationic Fullerene Quinazolinone Conjugates and Their Binding Mode with Modeled Mycobacterium Tuberculosis Hypoxanthine-Guanine Phosphoribosyltransferase Enzyme","volume":"19","author":"Patel","year":"2013","journal-title":"J. Mol. Model."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11224-018-1100-x","article-title":"Fullerene Quinazolinone Conjugates Targeting Mycobacterium Tuberculosis: A Combined Molecular Docking, QSAR, and ONIOM Approach","volume":"29","author":"Mirchi","year":"2018","journal-title":"Struct. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1021\/acsinfecdis.7b00275","article-title":"2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium Tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization","volume":"4","author":"Murugesan","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00044-019-02313-9","article-title":"Design, Synthesis and Molecular Docking Studies of Quinazolin-4-Ones Linked to 1,2,3-Triazol Hybrids as Mycobacterium Tuberculosis H37Rv Inhibitors besides Antimicrobial Activity","volume":"28","author":"Maddali","year":"2019","journal-title":"Med. Chem. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103774","DOI":"10.1016\/j.bioorg.2020.103774","article-title":"Benzimidazoquinazo-lines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation","volume":"99","author":"Jadhavar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_20","unstructured":"(2015). nticancer Activity of a Novel Quinazolinone-Chalcone Derivative through Cell Cycle Arrest in Pancreatic Cancer Cell Line. J. Solid Tumors, 5, 73\u201385."},{"key":"ref_21","first-page":"333","article-title":"Synthesis and Screening of Some New Fluorinated Quinazolinone-Sulphonamide Hybrids as Anticancer Agents","volume":"10","author":"Zayed","year":"2015","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3987\/COM-15-13389","article-title":"Design, Synthesis and Anticancer Activity of Novel 2,3-and 2,4-Disubstituted Quinazoline and Quinazolinone Derivatives","volume":"92","author":"Morsy","year":"2016","journal-title":"Heterocycles"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jsps.2017.04.022","article-title":"Synthesis and Anticancer Activity of New Quinazoline Derivatives","volume":"25","author":"Abuelizz","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/14756366.2017.1368504","article-title":"Synthesis, in Vitro Antitumour Activity, and Molecular Docking Study of Novel 2-Substituted Mercapto-3-(3,4,5-Trimethoxybenzyl)-4(3H)-Quinazolinone Analogues","volume":"32","author":"Ghabbour","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4155\/fmc-2017-0284","article-title":"Design, Synthesis and Biological Evaluation of Some Novel Quinazolinone Derivatives as Potent Apoptotic Inducers","volume":"10","author":"Nowar","year":"2018","journal-title":"Future Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Noser, A.A., El-Naggar, M., Donia, T., and Abdelmonsef, A.H. (2020). Abdelmonsef, Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition. Molecules, 25.","DOI":"10.3390\/molecules25204780"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bmcl.2011.11.007","article-title":"Synthesis and Anticonvulsant Evaluation of Some New 2,3,8-Trisubstituted- 4(3H)-Quinazoline Derivatives","volume":"22","author":"Eltahir","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_28","first-page":"104","article-title":"New Fluorinated Quinazolinone Derivatives as Anticonvulsant Agents","volume":"9","author":"Zayed","year":"2014","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bmcl.2015.02.025","article-title":"Synthesis, Anticonvulsant Activity and Molecular Modeling Study of Some New Hydrazinecarbothioamide, Benzenesulfonohydrazide, and Phenacylacetohydrazide Analogues of 4(3H)-Quinazolinone","volume":"25","author":"Hegazy","year":"2015","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"44435","DOI":"10.1039\/C6RA01284A","article-title":"Anti-Convulsant Potential of Quinazolinones","volume":"6","author":"Patel","year":"2016","journal-title":"RSC Adv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00706-016-1710-1","article-title":"Synthesis of Some New Quinazolin-4(3H)-One Derivatives and Evaluation of Their Anticonvulsant Activity","volume":"147","author":"Boshta","year":"2016","journal-title":"Mon. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22071094","article-title":"Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives","volume":"22","author":"Abuelizz","year":"2017","journal-title":"Molecules"},{"key":"ref_33","unstructured":"Patel, S. (2021). The Antiepileptic Effect of Synthesized Derivatives of Quinazoline-4(3H)-One. B R Nahata Smriti Sansthan Int. J. Phramaceutical Sci. Clin. Res., 1."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bioorg.2017.07.014","article-title":"Synthesis and Biological Evaluation of Quinazolinone-Based Hydrazones with Potential Use in Alzheimer\u2019s Disease","volume":"74","author":"Haghighijoo","year":"2017","journal-title":"Bioorg. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.22270\/jddt.v12i5.5625","article-title":"Synthesis and Virtual Screening of Some Novel Quinazolinone Derivatives as Potent Cholinesterase Inhibitors against Alzheimer\u2019s Disease","volume":"12","author":"Kachhadiya","year":"2022","journal-title":"J. Drug Deliv. Ther. JDDT"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.arabjc.2010.09.014","article-title":"Synthesis of New Azetidinonyl\/Thiazolidinonyl Quinazolinone Derivatives as Antiparkinsonian Agents","volume":"5","author":"Kumar","year":"2012","journal-title":"Arab. J. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11030-015-9623-1","article-title":"Synthesis and Antidepressant Activities of 4-(Substituted-Phenyl)Tetrazolo [1,5-a]Quinazolin-5(4H-Ones and Their Derivatives","volume":"19","author":"Zhang","year":"2015","journal-title":"Mol. Divers."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105822","DOI":"10.1016\/j.bioorg.2022.105822","article-title":"Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies","volume":"124","author":"Yamali","year":"2022","journal-title":"Bioorganic Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12272-013-0192-5","article-title":"Synthesis of Thioether Derivatives of Quinazoline-4-One-2-Thione and Evaluation of Their Antiplatelet Aggregation Activity","volume":"37","author":"Eskandariyan","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"ref_40","first-page":"43","article-title":"Synthesis and Evaluation of Quinazolinone Derivatives for Cardiovascular Activities","volume":"13","author":"Singh","year":"2013","journal-title":"Glob. J. Inc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871524914666140825144729","article-title":"Synthesis and Antihypertensive Activity of Novel Quinazolin-4(3H)-One Derivatives","volume":"14","author":"Pathak","year":"2014","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bmj.2.5404.288","article-title":"quinethazone, a new oral diuretic","volume":"2","author":"Sandler","year":"1964","journal-title":"Br. Med. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Pele, R., Marc, G., Stana, A., Ionu\u021b, I., Nastas\u0103, C., Tiperciuc, B., Oniga, I., P\u00eern\u0103u, A., Vlase, L., and Oniga, O. (2022). Synthesis of New Phenolic Derivatives of Quinazolin-4(3H)-One as Potential Antioxidant Agents\u2014In Vitro Evaluation and Quantum Studies. Molecules, 27.","DOI":"10.3390\/molecules27082599"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A Major Update to the DrugBank Database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/molecules20010573","article-title":"Halofuginone\u2014The Multifaceted Molecule","volume":"20","author":"Pines","year":"2015","journal-title":"Molecules"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","article-title":"FDA-Approved Small-Molecule Kinase Inhibitors","volume":"36","author":"Wu","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_47","unstructured":"PubChem Database (2019, November 23). National Center for Biotechnology Information, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov."},{"key":"ref_48","first-page":"693","article-title":"Thymitaq (Zarix)","volume":"2","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1080\/00397911.2018.1490433","article-title":"New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: Synthesis and cytotoxic evaluation","volume":"48","author":"Hekal","year":"2018","journal-title":"Synth. Commun."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/3\/978\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:09:34Z","timestamp":1760119774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/3\/978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["molecules28030978"],"URL":"https:\/\/doi.org\/10.3390\/molecules28030978","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}